Favorite  |  Set Home
Product name : BGB-283
Item : c2362
Price : 200mg, $1750;500mg, $2890; 1g, $3950; 2g, $6490
contact : Send inquiry to: info@acesobio.com
CAS : 1446090-77-2
Molecular Weight : 478.42
Formula : 162635-04-3
Storage : at -20°C
Additional information : We offer significant discount for bulky quantity order.
 Enlarge Image                   Back
←[Previous Product]              [Next Product]→

Description of:BGB-283
BGB-283(CAS:1446090-77-2), also known as Beigene-283 or Lifirafenib, is a Novel potent and selective RAF Kinase and EGFR inhibitor.
BGB-283 potently inhibits BRafV600E-activated ERK phosphorylation and cell proliferation. It demonstrates selective cytotoxicity and preferentially inhibits proliferation of cancer cells harboring BRafV600E and EGFR mutation/plification. In BRafV600E colorectal cancer cell lines, BGB-283 effectively inhibits the reactivation of EGFR and EGFR-mediated cell proliferation.

Quality control data:
Quality control by 1H-NMR, 13C-NMR, HPLC and LCMS.
Product will be shipped with supporting analytical data. 


1: Tang Z, Yuan X, Du R, Cheung SH, Zhang G, Wei J, Zhao Y, Feng Y, Peng H, Zhang
Y, Du Y, Hu X, Gong W, Liu Y, Gao Y, Liu Y, Hao R, Li S, Wang S, Ji JF, Zhang LH,
Li S, Sutton D, Wei M, Zhou C, Wang L, Luo L. BGB-283, a Novel RAF Kinase and
EGFR inhibitor, Displays Potent Antitumor Activity in B-RAF Mutated Colorectal
Cancers. Mol Cancer Ther. 2015 Jul 24. pii: molcanther.0262.2015. [Epub ahead of
print] PubMed PMID: 26208524.

Related Products :
PF-06463922 (Synonyms: Lorlatinib)
PF-06463922 (Synonyms: Lorlatinib)
Price: 200mg, $750;500mg, $1290; 1g, $1990; 2g, $2995
Price: 200mg, $750;500mg, $1290; 1g, $1990; 2g, $2995
Price: 200mg, $659;500mg, $1050; 1g $1595; 2g, $2355